
Melexis NV
XBRU:MELE

Intrinsic Value
The intrinsic value of one
MELE
stock under the Base Case scenario is
60.65
EUR.
Compared to the current market price of 45.62 EUR,
Melexis NV
is
Undervalued by 25%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Melexis NV
Fundamental Analysis


Revenue & Expenses Breakdown
Melexis NV
Balance Sheet Decomposition
Melexis NV
Current Assets | 450.9m |
Cash & Short-Term Investments | 38.6m |
Receivables | 148.1m |
Other Current Assets | 264.3m |
Non-Current Assets | 440.2m |
PP&E | 212.5m |
Intangibles | 1.5m |
Other Non-Current Assets | 226.2m |
Free Cash Flow Analysis
Melexis NV
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Melexis NV
Revenue
|
985.9m
EUR
|
Cost of Revenue
|
-550.4m
EUR
|
Gross Profit
|
435.5m
EUR
|
Operating Expenses
|
-181.6m
EUR
|
Operating Income
|
253.8m
EUR
|
Other Expenses
|
-50.8m
EUR
|
Net Income
|
203m
EUR
|
MELE Profitability Score
Profitability Due Diligence
Melexis NV's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Score
Melexis NV's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
MELE Solvency Score
Solvency Due Diligence
Melexis NV's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Score
Melexis NV's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MELE Price Targets Summary
Melexis NV
According to Wall Street analysts, the average 1-year price target for
MELE
is 66.58 EUR
with a low forecast of 55.55 EUR and a high forecast of 79.8 EUR.
Dividends
Current shareholder yield for MELE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MELE
stock under the Base Case scenario is
60.65
EUR.
Compared to the current market price of 45.62 EUR,
Melexis NV
is
Undervalued by 25%.